Copyright Reports & Markets. All rights reserved.

Global and United States Drug Discovery Technologies Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Drug Discovery Technologies Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Biochips
    • 1.2.3 High throughput screening
    • 1.2.4 Pharmacogenomics
    • 1.2.5 Genomics
    • 1.2.6 Bioanalytical instruments
    • 1.2.7 Bioinformatics
    • 1.2.8 Nanotechnology
    • 1.2.9 Others
  • 1.3 Market by Application
    • 1.3.1 Global Drug Discovery Technologies Market Share by Application: 2020 VS 2026
    • 1.3.2 Biopharmaceutical companies
    • 1.3.3 Pharmaceutical companies
    • 1.3.4 Research institutes
    • 1.3.5 Biotech companies
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Drug Discovery Technologies Market Perspective (2015-2026)
  • 2.2 Global Drug Discovery Technologies Growth Trends by Regions
    • 2.2.1 Drug Discovery Technologies Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Drug Discovery Technologies Historic Market Share by Regions (2015-2020)
    • 2.2.3 Drug Discovery Technologies Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Drug Discovery Technologies Players by Market Size
    • 3.1.1 Global Top Drug Discovery Technologies Players by Revenue (2015-2020)
    • 3.1.2 Global Drug Discovery Technologies Revenue Market Share by Players (2015-2020)
  • 3.2 Global Drug Discovery Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Drug Discovery Technologies Revenue
  • 3.4 Global Drug Discovery Technologies Market Concentration Ratio
    • 3.4.1 Global Drug Discovery Technologies Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Drug Discovery Technologies Revenue in 2019
  • 3.5 Key Players Drug Discovery Technologies Area Served
  • 3.6 Key Players Drug Discovery Technologies Product Solution and Service
  • 3.7 Date of Enter into Drug Discovery Technologies Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Drug Discovery Technologies Breakdown Data by Type (2015-2026)

  • 4.1 Global Drug Discovery Technologies Historic Market Size by Type (2015-2020)
  • 4.2 Global Drug Discovery Technologies Forecasted Market Size by Type (2021-2026)

5 Drug Discovery Technologies Breakdown Data by Application (2015-2026)

  • 5.1 Global Drug Discovery Technologies Historic Market Size by Application (2015-2020)
  • 5.2 Global Drug Discovery Technologies Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Drug Discovery Technologies Market Size (2015-2026)
  • 6.2 North America Drug Discovery Technologies Market Size by Type (2015-2020)
  • 6.3 North America Drug Discovery Technologies Market Size by Application (2015-2020)
  • 6.4 North America Drug Discovery Technologies Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Drug Discovery Technologies Market Size (2015-2026)
  • 7.2 Europe Drug Discovery Technologies Market Size by Type (2015-2020)
  • 7.3 Europe Drug Discovery Technologies Market Size by Application (2015-2020)
  • 7.4 Europe Drug Discovery Technologies Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Drug Discovery Technologies Market Size (2015-2026)
  • 8.2 China Drug Discovery Technologies Market Size by Type (2015-2020)
  • 8.3 China Drug Discovery Technologies Market Size by Application (2015-2020)
  • 8.4 China Drug Discovery Technologies Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Drug Discovery Technologies Market Size (2015-2026)
  • 9.2 Japan Drug Discovery Technologies Market Size by Type (2015-2020)
  • 9.3 Japan Drug Discovery Technologies Market Size by Application (2015-2020)
  • 9.4 Japan Drug Discovery Technologies Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Drug Discovery Technologies Market Size (2015-2026)
  • 10.2 Southeast Asia Drug Discovery Technologies Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Drug Discovery Technologies Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Drug Discovery Technologies Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Agilent Technologies, Inc
    • 11.1.1 Agilent Technologies, Inc Company Details
    • 11.1.2 Agilent Technologies, Inc Business Overview
    • 11.1.3 Agilent Technologies, Inc Drug Discovery Technologies Introduction
    • 11.1.4 Agilent Technologies, Inc Revenue in Drug Discovery Technologies Business (2015-2020))
    • 11.1.5 Agilent Technologies, Inc Recent Development
  • 11.2 Abbott Laboratories, Inc.
    • 11.2.1 Abbott Laboratories, Inc. Company Details
    • 11.2.2 Abbott Laboratories, Inc. Business Overview
    • 11.2.3 Abbott Laboratories, Inc. Drug Discovery Technologies Introduction
    • 11.2.4 Abbott Laboratories, Inc. Revenue in Drug Discovery Technologies Business (2015-2020)
    • 11.2.5 Abbott Laboratories, Inc. Recent Development
  • 11.3 GE Healthcare Ltd.
    • 11.3.1 GE Healthcare Ltd. Company Details
    • 11.3.2 GE Healthcare Ltd. Business Overview
    • 11.3.3 GE Healthcare Ltd. Drug Discovery Technologies Introduction
    • 11.3.4 GE Healthcare Ltd. Revenue in Drug Discovery Technologies Business (2015-2020)
    • 11.3.5 GE Healthcare Ltd. Recent Development
  • 11.4 Albany Molecular Research Inc.
    • 11.4.1 Albany Molecular Research Inc. Company Details
    • 11.4.2 Albany Molecular Research Inc. Business Overview
    • 11.4.3 Albany Molecular Research Inc. Drug Discovery Technologies Introduction
    • 11.4.4 Albany Molecular Research Inc. Revenue in Drug Discovery Technologies Business (2015-2020)
    • 11.4.5 Albany Molecular Research Inc. Recent Development
  • 11.5 Affymetrix Inc.
    • 11.5.1 Affymetrix Inc. Company Details
    • 11.5.2 Affymetrix Inc. Business Overview
    • 11.5.3 Affymetrix Inc. Drug Discovery Technologies Introduction
    • 11.5.4 Affymetrix Inc. Revenue in Drug Discovery Technologies Business (2015-2020)
    • 11.5.5 Affymetrix Inc. Recent Development
  • 11.6 Arqule Inc.
    • 11.6.1 Arqule Inc. Company Details
    • 11.6.2 Arqule Inc. Business Overview
    • 11.6.3 Arqule Inc. Drug Discovery Technologies Introduction
    • 11.6.4 Arqule Inc. Revenue in Drug Discovery Technologies Business (2015-2020)
    • 11.6.5 Arqule Inc. Recent Development
  • 11.7 Luminex Corporation
    • 11.7.1 Luminex Corporation Company Details
    • 11.7.2 Luminex Corporation Business Overview
    • 11.7.3 Luminex Corporation Drug Discovery Technologies Introduction
    • 11.7.4 Luminex Corporation Revenue in Drug Discovery Technologies Business (2015-2020)
    • 11.7.5 Luminex Corporation Recent Development
  • 11.8 Bayer Healthcare AG
    • 11.8.1 Bayer Healthcare AG Company Details
    • 11.8.2 Bayer Healthcare AG Business Overview
    • 11.8.3 Bayer Healthcare AG Drug Discovery Technologies Introduction
    • 11.8.4 Bayer Healthcare AG Revenue in Drug Discovery Technologies Business (2015-2020)
    • 11.8.5 Bayer Healthcare AG Recent Development
  • 11.9 Novartis AG
    • 11.9.1 Novartis AG Company Details
    • 11.9.2 Novartis AG Business Overview
    • 11.9.3 Novartis AG Drug Discovery Technologies Introduction
    • 11.9.4 Novartis AG Revenue in Drug Discovery Technologies Business (2015-2020)
    • 11.9.5 Novartis AG Recent Development
  • 11.10 Astrazeneca plc
    • 11.10.1 Astrazeneca plc Company Details
    • 11.10.2 Astrazeneca plc Business Overview
    • 11.10.3 Astrazeneca plc Drug Discovery Technologies Introduction
    • 11.10.4 Astrazeneca plc Revenue in Drug Discovery Technologies Business (2015-2020)
    • 11.10.5 Astrazeneca plc Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Drug Discovery Technologies Scope and Market Size
    Drug Discovery Technologies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drug Discovery Technologies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Biochips
    High throughput screening
    Pharmacogenomics
    Genomics
    Bioanalytical instruments
    Bioinformatics
    Nanotechnology
    Others

    Market segment by Application, split into
    Biopharmaceutical companies
    Pharmaceutical companies
    Research institutes
    Biotech companies

    Based on regional and country-level analysis, the Drug Discovery Technologies market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Drug Discovery Technologies market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Agilent Technologies, Inc
    Abbott Laboratories, Inc.
    GE Healthcare Ltd.
    Albany Molecular Research Inc.
    Affymetrix Inc.
    Arqule Inc.
    Luminex Corporation
    Bayer Healthcare AG
    Novartis AG
    Astrazeneca plc

    Buy now